(Q33364359)

English

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies (English)
0 references
0 references
Hendrik W Van Deventer
Dixie-Lee Esseltine

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit